Maximum supportive care, standard conditioning and allogeneic stem cell transplantation for elderly patients with acute myelogenous leukemia

Current Opinion in Oncology

Volumn 21, Issue SUPPL. 1, 2009, Pages

  Petersen, Finn B ^a,b   Ford, Clyde D ^a  

^a Intermountain Blood and Marrow Transplant Program   (United States)

^b LDS HOSPITAL   (United States)

Author keywords

Acute myelogenous leukaemia; Allogeneic stem cell transplantation; Conditioning regimens; Elderly patients; Preparative regimens

Indexed keywords

ACICLOVIR; AMPHOTERICIN B DEOXYCHOLATE; BUSULFAN; CYCLOPHOSPHAMIDE; ENOXAPARIN; LEVOFLOXACIN; METHOTREXATE; MICAFUNGIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PALIFERMIN; TACROLIMUS; URSODEOXYCHOLIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; AREA UNDER THE CURVE; CANDIDIASIS; CONTINUOUS INFUSION; DISEASE COURSE; DOSE RESPONSE; DRUG TARGETING; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; GRAM NEGATIVE INFECTION; GROUPS BY AGE; HERPES SIMPLEX; HUMAN; HYPOTHESIS; MORBIDITY; MORTALITY; MOULD; MYCOSIS; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; PARANASAL SINUS DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; REDUCED INTENSITY CONDITIONING; RELAPSE; SHORT SURVEY; SINUSOIDAL OBSTRUCTION SYNDROME; TREATMENT DURATION;

AGE FACTORS; AGED; HEALTH SERVICES FOR THE AGED; HUMANS; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 68049112544     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cco.0000357468.45843.5e     Document Type: Short Survey

References (13)

1. National Cancer Institute. Surveillance Epidemiology and End Results. SEER stat fact sheets acute myeloid leukemia. 17 November 2008. Available from: http://seer.cancer.gov/statfacts/html/amyl.html#ref1. Accessed: May 2009.
2. Kantarjian H, O'Brien S, Cortes J, et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer 2006; 106:1090-1098.
3. Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood 2006; 107:3481-3485.
4. Gupta V, Lazarus HM, Keating A. Myeloablative conditioning regimens for AML allografts: 30 years later. Bone Marrow Transplant 2003; 32:969-978.
5. Hegenbart U, Niederwieser D, Sandmaier BM, et al. Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors. J Clin Oncol 2006; 24:444-453.
6. Dombret H, Raffoux E, Gardin C. Acute myeloid leukemia in the elderly. Semin Oncol 2008; 35:430-438.
7. Stasi R, Venditti A, Del Poeta G, et al. High-dose chemotherapy in adult acute myeloid leukemia: rationale and results. Leuk Res 1996; 20:535-549.
8. Braess J, Fiegl M, Lorenz I, et al. Modeling the pharmacodynamics of highly schedule-dependent agents: exemplified by cytarabine-based regimens in acute myeloid leukemia. Clin Cancer Res 2005; 11:7415-7425.
9. Novitzky N, Thomas V, Abrahams L, et al. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia. Am J Hematol 2004; 76:319-329.
10. Savarese DM, Hsieh C, Stewart FM. Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors. J Clin Oncol 1997; 15:2981-2995.
11. Clift RA, Buckner CD, Appelbaum FR, et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood 1990; 76:1867-1871.
12. Thomas ED, Clift RA, Hersman J, et al. Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation. Int J Radiat Oncol Biol Phys 1982; 8:817-821.
13. Andersson BS, Gajewski J, Donato M, et al. Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy). Bone Marrow Transplant 2000; 25 (Suppl. 2):S35-S38.